News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Novartis
NEWS
JOBS
IN THE PRESS
NEWS
Business
Novartis AG Ponders Over Spin Off, IPO of Alcon Eye Unit
January 25, 2017
·
1 min read
Business
Earnings Preview: Here’s a Look at What to Expect From 7 Biopharmas
January 23, 2017
·
3 min read
BioCapital
How Trump’s Tax Cuts Could Propel Novartis AG to Invest More in the U.S.
January 18, 2017
·
1 min read
Biotech Bay
Novartis AG Launches First-Of-Its-Kind Heart Failure Social Network
January 9, 2017
·
1 min read
Policy
Novartis AG Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide at Nearby Hotel
January 4, 2017
·
2 min read
Business
Gilead Poaches Cancer R&D Superstar From Novartis AG
January 4, 2017
·
3 min read
Deals
Novartis AG Rumored to Be Buying Intercept Pharma
December 29, 2016
·
2 min read
Deals
Sun Pharma to Acquire Cancer Product from Novartis AG for $175 Million
December 22, 2016
·
2 min read
Deals
Novartis AG Snaps Up Mid-Stage Eczema Rival
December 16, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Novartis Canada Reopens NOYCIA 2026, Continuing Its Longstanding Investment in the Future of Oncology Research
March 30, 2026
·
2 min read
Press Releases
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
March 30, 2026
·
10 min read
Press Releases
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
March 27, 2026
·
6 min read
Press Releases
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
March 23, 2026
·
5 min read
Press Releases
Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
March 20, 2026
·
2 min read
Press Releases
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
March 20, 2026
·
6 min read
Press Releases
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
March 15, 2026
·
11 min read
Press Releases
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
March 6, 2026
·
4 min read
Press Releases
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
March 1, 2026
·
8 min read
Press Releases
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
March 1, 2026
·
4 min read
